We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$4.62B
1-Year Est. Return
29.71%
This Fund
S&P 500
This Quarter
Est. Return
+19.07%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.44B
AUM Growth
+$344M
(+31%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
11.87%
Top 10 Holdings %
Top 10 Hldgs %
38.33%
Holding
267
New
32
Increased
87
Reduced
92
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Preferred Securities and Income ETF
FPE
|
+$65.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$55.9M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$55.4M |
| 4 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$46.3M |
| 5 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$144M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$72.2M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$16.3M |
| 4 |
VanEck High Yield Muni ETF
HYD
|
+$12.4M |
| 5 |
RTN
Raytheon Company
RTN
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.45% |
| 2 | Healthcare | 7.84% |
| 3 | Industrials | 4.96% |
| 4 | Financials | 4.44% |
| 5 | Consumer Discretionary | 3.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Lincoln National
LNC
$8.73B
| $229K | 0.02% |
+6,228
| New | +$219K |
|
|
UN
227
DELISTED
Unilever NV New York Registry Shares
UN
| $227K | 0.02% |
+4,262
| New | +$217K |
|
228
Public Storage
PSA
$60.5B
| $223K | 0.02% |
+1,162
| New | +$224K |
|
229
Adobe
ADBE
$99.5B
| $222K | 0.02% |
+510
| New | +$189K |
|
230
Baidu
BIDU
$37.7B
| $219K | 0.02% |
+1,823
| New | +$195K |
|
231
L3Harris
LHX
$51.6B
| $205K | 0.01% |
1,210
-375
| -24% | -$70.5K |
|
232
iShare MSCI Eurozone ETF
EZU
$9.64B
| $202K | 0.01% |
+5,533
| New | +$185K |
|
233
Regions Financial
RF
$26.4B
| $128K | 0.01% |
11,502
| – | – |
|
234
JetBlue
JBLU
$2.28B
| $126K | 0.01% |
11,589
-352,969
| -97% | -$3.48M |
|
235
Ironwood Pharmaceuticals
IRWD
$696M
| $117K | 0.01% |
11,385
-5,715
| -33% | -$58.5K |
|
236
Huntington Bancshares
HBAN
$34.4B
| $112K | 0.01% |
12,373
-350
| -3% | -$3.1K |
|
|
CALA
237
DELISTED
Calithera Biosciences, Inc
CALA
| $110K | 0.01% |
1,045
-220
| -17% | -$26.1K |
|
|
LJPC
238
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $100K | 0.01% |
23,500
| – | – |
|
239
Ford
F
$58.5B
| $64K | ﹤0.01% |
10,497
| – | – |
|
|
AGRX
240
DELISTED
Agile Therapeutics
AGRX
| $59K | ﹤0.01% |
11
+1
| +10% | +$5.2K |
|
241
ASE Group
ASX
$77.3B
| $51K | ﹤0.01% |
11,174
-512
| -4% | -$2.18K |
|
|
MRNS
242
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $42K | ﹤0.01% |
+4,125
| New | +$37.9K |
|
243
Ribbon Communications
RBBN
$377M
| $39K | ﹤0.01% |
10,030
| – | – |
|
244
Genworth Financial
GNW
$3.76B
| $31K | ﹤0.01% |
13,225
| – | – |
|
|
RGLS
245
DELISTED
Regulus Therapeutics
RGLS
| $13K | ﹤0.01% |
+1,950
| New | +$12.8K |
|
|
AAC
246
DELISTED
AAC Holdings
AAC
| $2K | ﹤0.01% |
60,454
| – | – |
|
247
Albemarle
ALB
$13.9B
| – | – |
-80,854
| Closed | -$4.56M |
|
248
BorgWarner
BWA
$13.1B
| – | – |
-223,706
| Closed | -$4.8M |
|
|
249
VanEck High Yield Muni ETF
HYD
$4.43B
| – | – |
-237,744
| Closed | -$12.4M |
|
250
Innoviva
INVA
$1.55B
| – | – |
-12,800
| Closed | -$151K |
|
Similar funds
DWM
ANTB
VCM
ACM
AG
SCM
ASC
CWG
Grimes & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Grimes & Company held 267 positions worth $1.44B, up 31% from $1.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Grimes & Company deployed $171M of net new capital in Q2 2020, opening 32 new positions and adding to 87 existing holdings. Its largest new stake was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $144M trimmed.
- Grimes & Company's largest Q2 2020 buy was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.
- Grimes & Company added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $55.9M increase.
- Grimes & Company's biggest Q2 2020 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $144M.
- Grimes & Company fully exited VanEck High Yield Muni ETF in Q2 2020, selling an estimated $12.4M.
- Grimes & Company's ten largest holdings make up 38% of its $1.44B portfolio in Q2 2020.
- Grimes & Company opened 32 new positions and closed 18 in Q2 2020.
- Grimes & Company's portfolio value rose 31% quarter-over-quarter to $1.44B.
Based on Grimes & Company's 13F filing for Q2 2020, filed 31 Jul 2020.